Dr. Stephen Grubbs on Measuring Value in Oncology

Video

Stephen S. Grubbs, MD, senior director of the new clinical affairs department of the American Society of Clinical Oncology (ASCO) discusses value-based oncology.

Stephen S. Grubbs, MD, senior director of the new clinical affairs department of the American Society of Clinical Oncology (ASCO) discusses value-based oncology.

The field of oncology is moving toward a value-based system, where doctors will be gauged on the value on their care instead of individual components, says Grubbs. In the past oncology has mostly been a fee-for-service model.

In order for a value-based model to work, it must first be determined how value can be measured, he says. There must be a structured approach to how value will be measured in the long run.

ASCO is putting together a framework to determine how to define value. There is currently a framework that has been published, which is open for consideration, says Grubbs.

Related Videos
Jorge J. Castillo, MD,
Heinz-Josef Lenz, MD, FACP
Sundar Jagannath, MBBS, director, Center of Excellence for Multiple Myeloma, professor of medicine (hematology and medical oncology), The Tisch Cancer Institute, Mount Sinai
Omid Hamid, MD, professor, medicine, Cedars-Sinai; director, Clinical Research and Immunotherapy, director, Cutaneous Oncology and Melanoma, The Angeles Clinic and Research Institute
Christina L. Roland, MD, MS, FACS
Ashish Saxena, MD, PhD
Shruti Tiwari, MD
Scott Kopetz, MD, PhD, FACP
Katharina Hoebel, MD, PhD
Catherine C. Coombs, MD, associate clinical professor, medicine, University of California, Irvine School of Medicine